Physician

Abraham Abdulhak, MD

According to 2025 Medicare claims, Abraham Abdulhak, MD (NPI: 1548752793) practices dermatology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from St. Clair, MI. This provider's primary affiliated billing organization is S L HUSAIN HAMZAVI MD PC (NPI: 1407943962; TIN: 382387637) and primary practice location at 48059-3526.

Abdulhak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 312 traditional Medicare patients, billed 862 HCPCS/CPT codes, and received $239,431 in Medicare payments. The top billing code was 17313 (Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks). Part D data shows 110 prescription claims across 73 beneficiaries totaling $2,778 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 7 records totaling $197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $589 to $2,778. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$120K$239K2023 Medicare payment: $70,500 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $239,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202393262$70,500
2024312862$239,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$93K$186K2018 Drug cost: $589 (USD; Tot_Drug_Cst)2019 Drug cost: $16,336 (USD; Tot_Drug_Cst)2020 Drug cost: $172,344 (USD; Tot_Drug_Cst)2021 Drug cost: $186,181 (USD; Tot_Drug_Cst)2022 Drug cost: $181,544 (USD; Tot_Drug_Cst)2023 Drug cost: $3,090 (USD; Tot_Drug_Cst)2024 Drug cost: $2,778 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181241$589
20193783$16,336
202055159$172,344
202172290$186,181
202283206$181,544
20237494$3,090
202473110$2,778

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks4446$463
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks206229$438
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks5971$310
13121Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm5356$215
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm5758$178

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil28809$1,530
Clobetasol PropionateClobetasol Propionate14364$345
Doxycycline HyclateDoxycycline Hyclate12156$49

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$197Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abraham Abdulhak, MD?

Tedicare shows public-source Medicare data for Abraham Abdulhak, MD (NPI 1548752793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Abdulhak, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abraham Abdulhak, MD?

Abraham Abdulhak, MD is linked to S L HUSAIN HAMZAVI MD PC (billing NPI 1407943962) in the available physician profile data.

Does Abraham Abdulhak, MD have Open Payments data?

Abraham Abdulhak, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.